Developer docs
API playgroundTry for free, no card

Search company profiles

Manifold

Full company profile

uuid0000i2m

Namestring
Manifold
Legal namestring
Manifold Inc.
Websiteurl
manifold.ai
Company typeenum
Private
Founded yearint
2016
Descriptiontext

Manifold is an Enterprise Agent Platform for Life Sciences, founded in 2016 and headquartered in Newton, Massachusetts. The company builds AI-powered infrastructure for biomedical research organizations, with stated focus on accelerating drug discovery, clinical research, and real-world evidence generation by automating the data preparation, cohort building, and analysis work that consumes the majority of life sciences R&D effort. Manifold serves biotech and pharma companies, molecular diagnostics firms, real-world data providers, omics service providers, academic medical centers, and biobanks — with named customers including Foundation Medicine, Broad Institute, American Cancer Society, Broad Clinical Labs, Champions Oncology, Indiana University, and Morehouse School of Medicine.

The platform centers on two core products: Agent OS, which enables design and deployment of purpose-built AI agents with compliance and governance foundations, and the Agent Data Platform, which harmonizes molecular, clinical, imaging, and real-world data for AI-ready analysis. Supporting modules include AI-powered cohort exploration, data catalog, data engineering with biomedical pipeline connectors (REDCap, OnCore, LIMS, EHR), batch bioinformatics for WDL/Nextflow workflows, Jupyter/RStudio workspaces, dashboards, collaborative workbenches, and observational study management. The architecture runs natively on AWS using a Bring Your Own Cloud (BYOC) deployment model that keeps customer data inside the customer's own AWS account, with fine-grained IAM and Lake Formation-based access controls. Compliance certifications span HIPAA, SOC 2 Type II, GDPR, NIST 800-171, 21 CFR Part 11, and TX-RAMP. The platform is built on the Model Context Protocol (MCP) and integrates domain-specialized agents for biostatistics, differential expression, spatial transcriptomics, and natural language cohort building across billions of clinical and genomic records.

Manifold operates an enterprise SaaS business model with subscription-based, quote-priced annual contracts sold through a direct field sales motion complemented by channel partnerships with AWS (including AWS Marketplace listing), Broad Institute, and Snowflake. The company has raised approximately $40 million across multiple equity rounds from investors including Reach Capital, TQ Ventures, TTCER Partners, Calibrate Ventures, SilverArc Capital, and Industry Ventures, and operates with a headcount of 101-250 employees. Notable strategic moves include the Broad Institute collaboration (2025), Foundation Medicine partnership (2025), and Series B close led by Reach Capital in December 2025 to fund Agent OS expansion.

Short descriptiontext

Manifold is an enterprise AI agent platform for life sciences, built on AWS with Bring Your Own Cloud deployment. It serves biotech, pharma, molecular diagnostics, academic medical centers, and biobanks with AI-powered data harmonization, cohort building, and bioinformatics workflows.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersNewton, United States
HQ citystring
Newton
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
life sciences AI platform, biomedical data harmonization, clinical research software, bioinformatics pipeline software, AI agent platform
Industry3 codes
PRIMARYHDAEANAJ
AI Application Enablement Platforms (Copilot/Agent Frameworks, SDKs)
Hardware, Technology & Telecom/Enterprise Platforms & Databases/Artificial Intelligence Platforms for Enterprise
SECONDARYHDAEANAH
Enterprise AI Data & Knowledge Platforms (Vector Databases, Knowledge Graphs)
Hardware, Technology & Telecom/Enterprise Platforms & Databases/Artificial Intelligence Platforms for Enterprise
SECONDARYHLAGAJAC
Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
NAICS code2 codes
  • Software Publishers513210
  • Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services518210
SIC code2 codes
  • Services-Prepackaged Software7372
  • Services-Computer Programming, Data Processing, Etc.7370
Product category
Life Sciences AI Platform
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Enterprise SaaS Platform Subscription
TypeSubscription Recurring
Description

Subscription-based enterprise software platform for life sciences organizations. Pricing likely per-seat, per-module, or enterprise-wide licensing based on data volumes and agent usage. Customers include pharma companies, academic medical centers, biobanks, and diagnostics companies.

manifold.ai
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Operations
Pricing details1 tier
1Enterprise platform with multiple modules (Agent OS, Data Platform, Agents, Study Management, etc.)
ModelSubscriptionBilling cadenceAnnual
Notes

Quote-based / Not publicly disclosed. Demo-driven sales motion with no public pricing page.

manifold.ai
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 3 records shown
1Agent OS
Description

AI platform enabling design and deployment of agents purpose-built for life sciences, with compliance and governance foundation.

manifold.ai
+2 more records
Core offering1 text field

Manifold sells an enterprise SaaS platform for life sciences that combines Agent OS (purpose-built AI agent deployment with compliance governance) and Agent Data Platform (governed harmonization of molecular, clinical, imaging, and real-world data). The platform automates data preparation, cohort building, biostatistics, and bioinformatics analysis through domain-specialized AI agents accessible via natural language, deployed into the customer's own AWS cloud.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • Weeks to minutes query turnaround for biospecimen and clinical data
+5 more records
Product overview1 text field

Manifold is an Enterprise Agent Platform for Life Sciences consisting of two core products—Agent OS and Agent Data Platform—plus multiple integrated platform components and sub-products. Agent OS enables design and deployment of purpose-built AI agents for life sciences workflows with built-in compliance and governance. Agent Data Platform provides the governed data foundation harmonizing molecular, clinical, imaging, and real-world data. The platform includes specialized AI agents for natural language data exploration and cohort building, data engineering and cataloging tools, batch bioinformatics (WDL/Nextflow), pre-configured data science environments (Jupyter/RStudio), collaborative workbenches, study management for observational research, and dashboarding capabilities. The architecture supports Bring Your Own Cloud deployment to customer AWS environments with zero data migration. Platform components cover governance, secure data sharing, and security & compliance across HIPAA, SOC 2, GDPR, and other frameworks.

Product and service2 records
1Agent OS
CategoryAI Agent Platform (Core)
Description

Purpose-built platform for designing and deploying AI agents in life sciences with built-in compliance and governance. Automates data preparation, tool setup, and analysis workflows for biomedical researchers. Targeted at life sciences organizations needing to operationalize AI agents on regulated biomedical data.

2Agent Data Platform
CategoryData Harmonization Platform (Core)
Description

Governed data foundation that harmonizes molecular, clinical, imaging, and real-world data for AI-ready analysis. Enables life sciences organizations to make AI investments work with properly structured, governed, and interoperable data.

Scale indicator13 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-04-23
Description

Partnership to bring genomic interpretation into the governed environment, unlocking precision medicine data for AI-ready research.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-04-08
Description

Partnership to accelerate creation of high quality, AI-ready biological datasets.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-10-30
Description

Partnership to accelerate drug discovery by integrating Manifold's AI capabilities into FoundationInsights® platform. Foundation Medicine's 800,000+ patient genomic dataset enhanced with AI-enabled analytics for biopharmaceutical partners. Natural language search and advanced analytics enabling faster cohort identification. Targeted version for healthcare providers planned for 2026.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2025-01-13
Description

Strategic collaboration to build next-generation AI-enabled life sciences research platform building on Terra principles. Manifold provides data infrastructure and AI capabilities while Broad expands focus on computational science tools. Platform will include bring your own cloud support, enhanced scalability, purpose-built AI agents for cohort building, natural language search, and automated survival/gene expression analysis.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-09-19
Description

Partnership to integrate social determinant and genomic data advancing cancer disparities research. Institute of Translational Genomic Medicine (ITGM) building modern data foundation using Cancer Data Science and Observational Study solutions. Initial focus on Polyethnic 1000 breast cancer cohort of African ancestry patients. Integrating geospatial, clinical, and genomic data for molecular attributes of cancer in underrepresented populations.

6American Cancer Society
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-07-18
Description

Collaboration to modernize observational study management for ACS's cancer research programs. Manifold platform supporting VOICES of Black Women study (100,000 participants over 30 years) and migration of Cancer Prevention Studies (1.5M participants, 11TB data). ACS using Manifold Observational Study technology for participant engagement, survey collection, and study operations.

manifold.ai
Strategic tierCoreTypeTechnology or Integration
Description

AWS Partner with Bring Your Own Cloud deployment model. Manifold deploys within customer's AWS account using Amazon S3, HealthOmics, EC2, SageMaker, Lake Formation, IAM, Glue, and Data Catalog. Platform available in AWS Marketplace. Architecture meets HIPAA, SOC 2, GDPR, 21 CFR Part 11, NIST 800-171 requirements.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Dominant cloud software provider for life sciences including clinical, regulatory, and quality. Overlaps with Manifold's clinical trial informatics, governance, and life sciences CRM use cases, but at much broader scale and as a public company incumbent.

2Tempus AI
TypeBroad incumbent
Description

Large-scale AI-powered precision medicine platform with multi-modal clinical and molecular data assets. Broader incumbent overlapping with Manifold's molecular diagnostics and pharma use cases, but with much larger scale.

TypeBroad incumbent
Description

Oncology-specific electronic health record and real-world data platform acquired by Roche. Comparable to Manifold's oncology and real-world data offerings but a much larger, established incumbent.

TypeDirect peer
Description

AI platform for medical and clinical research using multimodal patient data with federated learning. Comparable to Manifold in applying AI agents to multimodal biomedical data for pharma and academic research.

TypeBroad incumbent
Description

Enterprise data integration and AI platform widely deployed across pharma and biomedical research (including within NCI initiatives). Comparable to Manifold's data harmonization and agent-driven analytics but as a large, horizontal incumbent.

TypeDirect peer
Description

Genomic and real-world data management platform for pharma and biobanks with governed data sharing. Closely comparable to Manifold's biobank, RWD provider, and governed data sharing solutions.

TypeDirect peer
Description

R&D data cloud for life sciences, harmonizing lab instrument and scientific data for pharma. Comparable in its mission to harmonize life sciences data on cloud-native infrastructure with AI-ready outputs.

TypeDirect peer
Description

Bioinformatics workflow and biomedical data analysis platform with WDL/Nextflow pipeline support. Highly comparable to Manifold's Batch Bioinformatics and data harmonization capabilities.

TypeDirect peer
Description

Cloud-based genomic and biomedical data management and analytics platform serving pharma, diagnostics, and academic centers. Directly comparable as a regulated, cloud-native life sciences data and analysis platform competing for the same enterprise customers.

TypeEmerging player
Description

Trusted research environment for biomedical and clinical data analysis, often used in UK and EU research consortia. Comparable to Manifold's Trusted Research Environment and collaborative workbench offerings.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration20 records

Each record includes

Title, Type, Description, Source

AI capability11 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature12 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance7 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds5 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors9 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Manifold

Life Sciences AI Platformmanifold.ai

Manifold is an enterprise AI agent platform for life sciences, built on AWS with Bring Your Own Cloud deployment. It serves biotech, pharma, molecular diagnostics, academic medical centers, and biobanks with AI-powered data harmonization, cohort building, and bioinformatics workflows.

What Manifold does

Manifold is an Enterprise Agent Platform for Life Sciences, founded in 2016 and headquartered in Newton, Massachusetts. The company builds AI-powered infrastructure for biomedical research organizations, with stated focus on accelerating drug discovery, clinical research, and real-world evidence generation by automating the data preparation, cohort building, and analysis work that consumes the majority of life sciences R&D effort. Manifold serves biotech and pharma companies, molecular diagnostics firms, real-world data providers, omics service providers, academic medical centers, and biobanks — with named customers including Foundation Medicine, Broad Institute, American Cancer Society, Broad Clinical Labs, Champions Oncology, Indiana University, and Morehouse School of Medicine.

The platform centers on two core products: Agent OS, which enables design and deployment of purpose-built AI agents with compliance and governance foundations, and the Agent Data Platform, which harmonizes molecular, clinical, imaging, and real-world data for AI-ready analysis. Supporting modules include AI-powered cohort exploration, data catalog, data engineering with biomedical pipeline connectors (REDCap, OnCore, LIMS, EHR), batch bioinformatics for WDL/Nextflow workflows, Jupyter/RStudio workspaces, dashboards, collaborative workbenches, and observational study management. The architecture runs natively on AWS using a Bring Your Own Cloud (BYOC) deployment model that keeps customer data inside the customer's own AWS account, with fine-grained IAM and Lake Formation-based access controls. Compliance certifications span HIPAA, SOC 2 Type II, GDPR, NIST 800-171, 21 CFR Part 11, and TX-RAMP. The platform is built on the Model Context Protocol (MCP) and integrates domain-specialized agents for biostatistics, differential expression, spatial transcriptomics, and natural language cohort building across billions of clinical and genomic records.

Manifold operates an enterprise SaaS business model with subscription-based, quote-priced annual contracts sold through a direct field sales motion complemented by channel partnerships with AWS (including AWS Marketplace listing), Broad Institute, and Snowflake. The company has raised approximately $40 million across multiple equity rounds from investors including Reach Capital, TQ Ventures, TTCER Partners, Calibrate Ventures, SilverArc Capital, and Industry Ventures, and operates with a headcount of 101-250 employees. Notable strategic moves include the Broad Institute collaboration (2025), Foundation Medicine partnership (2025), and Series B close led by Reach Capital in December 2025 to fund Agent OS expansion.

Manifold firmographics

Firmographics
Name
Manifold
Legal name
Manifold Inc.
Website
https://manifold.ai
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
51–100 employees
Short description
Manifold is an enterprise AI agent platform for life sciences, built on AWS with Bring Your Own Cloud deployment. It serves biotech, pharma, molecular diagnostics, academic medical centers, and biobanks with AI-powered data harmonization, cohort building, and bioinformatics workflows.
Ownership category
akta.pro rank

Manifold industry classification

Industry
Product category
Life Sciences AI Platform
NAICS
Software Publishers (513210), Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (518210)
SIC
Services-Prepackaged Software (7372), Services-Computer Programming, Data Processing, Etc. (7370)
akta.pro industry
PRIMARYHDAEANAJ
AI Application Enablement Platforms (Copilot/Agent Frameworks, SDKs)
Hardware, Technology & Telecom/Enterprise Platforms & Databases/Artificial Intelligence Platforms for Enterprise
SECONDARYHDAEANAH
Enterprise AI Data & Knowledge Platforms (Vector Databases, Knowledge Graphs)
Hardware, Technology & Telecom/Enterprise Platforms & Databases/Artificial Intelligence Platforms for Enterprise
SECONDARYHLAGAJAC
Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)

Keywords

  • Life sciences AI platform
  • Biomedical data harmonization
  • Clinical research software
  • Bioinformatics pipeline software
  • AI agent platform

Where Manifold is headquartered

Location

Headquarters

HQ city
Newton
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Manifold business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Operations

Revenue model

  1. Enterprise SaaS Platform Subscription: Subscription-based enterprise software platform for life sciences organizations. Pricing likely per-seat, per-module, or enterprise-wide licensing based on data volumes and agent usage. Customers include pharma companies, academic medical centers, biobanks, and diagnostics companies.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualEnterprise platform with multiple modules (Agent OS, Data Platform, Agents, Study Management, etc.)

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Manifold product offering

Product offering

Core offering

Manifold sells an enterprise SaaS platform for life sciences that combines Agent OS (purpose-built AI agent deployment with compliance governance) and Agent Data Platform (governed harmonization of molecular, clinical, imaging, and real-world data). The platform automates data preparation, cohort building, biostatistics, and bioinformatics analysis through domain-specialized AI agents accessible via natural language, deployed into the customer's own AWS cloud.

Product overview

Manifold is an Enterprise Agent Platform for Life Sciences consisting of two core products—Agent OS and Agent Data Platform—plus multiple integrated platform components and sub-products. Agent OS enables design and deployment of purpose-built AI agents for life sciences workflows with built-in compliance and governance. Agent Data Platform provides the governed data foundation harmonizing molecular, clinical, imaging, and real-world data. The platform includes specialized AI agents for natural language data exploration and cohort building, data engineering and cataloging tools, batch bioinformatics (WDL/Nextflow), pre-configured data science environments (Jupyter/RStudio), collaborative workbenches, study management for observational research, and dashboarding capabilities. The architecture supports Bring Your Own Cloud deployment to customer AWS environments with zero data migration. Platform components cover governance, secure data sharing, and security & compliance across HIPAA, SOC 2, GDPR, and other frameworks.

Differentiator

Problem solved

Functional benefit

Brands

  • Agent OS: AI platform enabling design and deployment of agents purpose-built for life sciences, with compliance and governance foundation.
  • Agent Data Platform
  • FoundationInsights (powered by Manifold)

Products and services

  • Agent OS Purpose-built platform for designing and deploying AI agents in life sciences with built-in compliance and governance. Automates data preparation, tool setup, and analysis workflows for biomedical researchers. Targeted at life sciences organizations needing to operationalize AI agents on regulated biomedical data.
  • Agent Data Platform Governed data foundation that harmonizes molecular, clinical, imaging, and real-world data for AI-ready analysis. Enables life sciences organizations to make AI investments work with properly structured, governed, and interoperable data.

Quantifiable outcome

  • Weeks to minutes query turnaround for biospecimen and clinical data
  • +5 more outcomes

Companies that use Manifold

Customer profile

Named customers8 records

Segments6 records

Ideal customer profiles4 records

Manifold technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration20 records

AI capability11 records

Feature12 records

Manifold partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered minor, core and flagship.

  • IntelliseqminorStrategic or Co-development Partner · 23 April 2026Partnership to bring genomic interpretation into the governed environment, unlocking precision medicine data for AI-ready research.
  • Savant BiominorStrategic or Co-development Partner · 8 April 2026Partnership to accelerate creation of high quality, AI-ready biological datasets.
  • Foundation MedicinecoreStrategic or Co-development Partner · 30 October 2025Partnership to accelerate drug discovery by integrating Manifold's AI capabilities into FoundationInsights® platform. Foundation Medicine's 800,000+ patient genomic dataset enhanced with AI-enabled analytics for biopharmaceutical partners. Natural language search and advanced analytics enabling faster cohort identification. Targeted version for healthcare providers planned for 2026.
  • Broad Institute of MIT and HarvardflagshipStrategic or Co-development Partner · 13 January 2025Strategic collaboration to build next-generation AI-enabled life sciences research platform building on Terra principles. Manifold provides data infrastructure and AI capabilities while Broad expands focus on computational science tools. Platform will include bring your own cloud support, enhanced scalability, purpose-built AI agents for cohort building, natural language search, and automated survival/gene expression analysis.
  • Morehouse School of MedicinecoreStrategic or Co-development Partner · 19 September 2024Partnership to integrate social determinant and genomic data advancing cancer disparities research. Institute of Translational Genomic Medicine (ITGM) building modern data foundation using Cancer Data Science and Observational Study solutions. Initial focus on Polyethnic 1000 breast cancer cohort of African ancestry patients. Integrating geospatial, clinical, and genomic data for molecular attributes of cancer in underrepresented populations.
  • American Cancer SocietycoreStrategic or Co-development Partner · 18 July 2024Collaboration to modernize observational study management for ACS's cancer research programs. Manifold platform supporting VOICES of Black Women study (100,000 participants over 30 years) and migration of Cancer Prevention Studies (1.5M participants, 11TB data). ACS using Manifold Observational Study technology for participant engagement, survey collection, and study operations.
  • Amazon Web Services (AWS)coreTechnology or IntegrationAWS Partner with Bring Your Own Cloud deployment model. Manifold deploys within customer's AWS account using Amazon S3, HealthOmics, EC2, SageMaker, Lake Formation, IAM, Glue, and Data Catalog. Platform available in AWS Marketplace. Architecture meets HIPAA, SOC 2, GDPR, 21 CFR Part 11, NIST 800-171 requirements.

Scale indicators13 records

Recent moves6 records

Expansion highlights7 records

Manifold competitors and assessment

Company assessment

Broad incumbents

  • Veeva Systems: Dominant cloud software provider for life sciences including clinical, regulatory, and quality. Overlaps with Manifold's clinical trial informatics, governance, and life sciences CRM use cases, but at much broader scale and as a public company incumbent.
  • Tempus AI: Large-scale AI-powered precision medicine platform with multi-modal clinical and molecular data assets. Broader incumbent overlapping with Manifold's molecular diagnostics and pharma use cases, but with much larger scale.
  • Flatiron Health: Oncology-specific electronic health record and real-world data platform acquired by Roche. Comparable to Manifold's oncology and real-world data offerings but a much larger, established incumbent.
  • Palantir Foundry: Enterprise data integration and AI platform widely deployed across pharma and biomedical research (including within NCI initiatives). Comparable to Manifold's data harmonization and agent-driven analytics but as a large, horizontal incumbent.

Direct peers

  • Owkin: AI platform for medical and clinical research using multimodal patient data with federated learning. Comparable to Manifold in applying AI agents to multimodal biomedical data for pharma and academic research.
  • BC Platforms: Genomic and real-world data management platform for pharma and biobanks with governed data sharing. Closely comparable to Manifold's biobank, RWD provider, and governed data sharing solutions.
  • TetraScience: R&D data cloud for life sciences, harmonizing lab instrument and scientific data for pharma. Comparable in its mission to harmonize life sciences data on cloud-native infrastructure with AI-ready outputs.
  • Seven Bridges (now part of Velsera): Bioinformatics workflow and biomedical data analysis platform with WDL/Nextflow pipeline support. Highly comparable to Manifold's Batch Bioinformatics and data harmonization capabilities.
  • DNAnexus (Velsera): Cloud-based genomic and biomedical data management and analytics platform serving pharma, diagnostics, and academic centers. Directly comparable as a regulated, cloud-native life sciences data and analysis platform competing for the same enterprise customers.

Emerging players

  • Aridhia Informatics: Trusted research environment for biomedical and clinical data analysis, often used in UK and EU research consortia. Comparable to Manifold's Trusted Research Environment and collaborative workbench offerings.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Manifold social profiles

Digital presence

Manifold compliance and trust

Trust signal

Compliance7 records

Manifold financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Manifold leadership team

Management profile

Number of profiles

Profiles10 records

Manifold funding detail

Funding detail

Funding overview

Funding rounds5 records

Investors9 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Manifold M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Manifold

What does Manifold do?

Manifold sells an enterprise SaaS platform for life sciences that combines Agent OS (purpose-built AI agent deployment with compliance governance) and Agent Data Platform (governed harmonization of molecular, clinical, imaging, and real-world data). The platform automates data preparation, cohort building, biostatistics, and bioinformatics analysis through domain-specialized AI agents accessible via natural language, deployed into the customer's own AWS cloud.

Is Manifold a public or private company?

Manifold is a private company. It is classified as venture growth investor backed and is currently operating.

When was Manifold founded?

Manifold was founded in 2016. It employs 51 to 100 people.

Where is Manifold based?

Manifold is headquartered in Newton, United States, in the North America region.

How does Manifold make money?

One revenue line is on record: enterprise SaaS Platform Subscription.

Who are Manifold's main competitors?

Broad incumbents on record are Veeva Systems, Tempus AI, Flatiron Health and Palantir Foundry. Direct peers are Owkin, BC Platforms, TetraScience, Seven Bridges (now part of Velsera) and DNAnexus (Velsera). Aridhia Informatics is listed as an emerging player.

Does Manifold have an API?

No public API is recorded for Manifold.

What industry is Manifold in?

Manifold's product category is Life Sciences AI Platform. Its primary akta.pro industry code is HDAEANAJ, AI Application Enablement Platforms (Copilot/Agent Frameworks, SDKs), with a secondary code of HDAEANAH, Enterprise AI Data & Knowledge Platforms (Vector Databases, Knowledge Graphs). Its NAICS code is 513210 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PharmExecThe Industry’s Shift on RWDCarelon Research president Mark Cziraky discussed the industry's shift toward real-world data (RWD) in an interview with Pharmaceutical Executive. The company signed a deal with Manifold to analyze Carelon RWD alongside third-party datasets. Cziraky said the shift reflects a need for deeper data integration and a trusted research environment.FinancialContent Business PageCarelon Research and Manifold Partner to Expand Real-World Evidence Access for Life Sciences ResearchersCarelon Research and Manifold announced a strategic partnership to provide life sciences researchers and data analysts access to high-quality, analysis-ready real-world data within a secure environment. The collaboration enables integrated dataset analysis without data transfer outside organizations, aiming to enhance evidence-based decision-making. The partnership supports a broad user base with tools for data discovery, analysis, and compliance.Business Wire BlogCarelon Research and Manifold Partner to Expand Real-World Evidence Access for Life Sciences ResearchersCarelon Research, a subsidiary of Elevance Health, and the enterprise platform Manifold announced a partnership to provide life sciences researchers with secure, scalable access to real-world data for evidence-based decision-making. This collaboration enables analysis of Carelon Real World Data alongside third-party datasets within a protected environment, supporting faster insights and addressing evidence gaps.Tech Funding NewsEx-Laiyer AI founders raise $8M at Manifold to tame agentic AI risks — TFNSan Diego-based AI security company Manifold has raised $8 million in seed funding led by Costanoa Ventures, with participation from Cherry Ventures, Rain Capital, and Modern Technical Fund, to build an AI Detection and Response platform that monitors autonomous AI agents at runtime on endpoints. The company was founded by Neal Swaelens and Oleksandr Yaremchuk, who previously co-founded Laiyer AI and built LLM Guard, one of the most widely used open-source tools for securing large language models. The platform addresses a growing security gap as AI tools evolve from chatbots to autonomous agents that execute commands, access systems, and interact with production environments, with around 85% of developers already using coding assistants.Pulse 2.0Manifold: $18 Million Series B Raised To Expand Vertical AI Platform For Life SciencesManifold has raised $18 million in a Series B financing round led by Reach Capital, with participation from SilverArc Capital, Industry Ventures, TQ Ventures, and Calibrate Ventures. This funding increases Manifold's total capital to $40 million, which will be used to enhance its AI platform aimed at improving workflows in life sciences. The company plans to refine its "Agent OS" to better support biomedical data use and bolster collaborative infrastructure among life sciences organizations.Business Wire BlogManifold Raises $18 Million Series B to Define Vertical AI for Life Sciences and Accelerate Life-changing Medicines to PatientsManifold announced an $18 million Series B funding round led by Reach Capital, bringing its total capital raised to $40 million. The company plans to use the funds to expand its AI platform capabilities for life sciences workflows and deepen collaboration infrastructure with partners like AWS and Anthropic. This investment positions Manifold as a leader in vertical AI for the life sciences sector.VC News DailyManifold Pulls In $18M Series B RoundManifold, an AI platform for life sciences based in Newton, Massachusetts, announced an $18 million Series B funding round led by Reach Capital with participation from SilverArc Capital, Industry Ventures, and existing investors TQ Ventures and Calibrate Ventures. The round brings the company's total capital raised to $40 million and positions Manifold as the emerging category leader in vertical AI for life sciences. The platform helps biopharma companies and medical centers accelerate workflows from target identification to clinical development and precision medicine.Venture Capital Access OnlineManifold Raises $18 Million Series B to Define Vertical AI for Life Sciences and Accelerate Life-changing Medicines to PatientsManifold, an AI platform for life sciences, announced an $18 million Series B funding round led by Reach Capital with participation from SilverArc Capital, Industry Ventures, and existing investors TQ Ventures and Calibrate Ventures, bringing its total capital raised to $40 million. The funding positions the company as the emerging category leader in vertical AI for life sciences, a market valued at $2 trillion, and will support expansion of its Agent OS platform, collaboration infrastructure, and data ecosystem. The company has grown its customer base to include Foundation Medicine, the University of Virginia, and strategic partners like the Broad Institute, AWS, and Anthropic while operating Terra for thousands of researchers globally.FoundationmedicineDriving Innovation Together: Helping Biopharmaceutical Partners Deliver BreakthroughsFoundation Medicine announced expanded offerings for biopharmaceutical partners, including an AI-enhanced FoundationInsights® analytics platform powered by Manifold, new multimodal real-world datasets with H&E whole slide images and RNA gene expression data, and a Tissue-Informed WGS MRD test for research use in cancer studies. The company also formed a partnership with Datavant to enable integration of their multimodal data with external sources like insurance claims data for enriched clinical insights. These solutions aim to accelerate drug development and bring personalized therapies to patients faster across cancer and other diseases.